SoGal's 2nd investment. We believe the future of healthcare is consumerized, accessible, and autonomous
$507M Actual Revenue
We believe the future of healthcare is consumerized, accessible, and autonomous and were delighted to discover Everlywell. We convinced Julia to take our $100K although her seed round was full.
We were able to help bring Series A investor back to the table when the deal almost didn't go through, negotiate valuations of financing rounds, and convince the current COO to join.
Julia later became a SoGal Fund I & II LP.
Everly Health became a unicorn in Q4 2020 and its valuation has grown 240X since we invested in 2017.